Send me real-time posts from this site at my email

Feb. 17 - Updates, Analyst Actions, Our Take - CRWD, IMGN

Notable updates, news, or analysts actions from our trading lists followed by 'Our Take'.


Crowdstrike initiated with a Buy at Canaccord

Canaccord Genuity analyst T. Michael Walkley initiated coverage of Crowdstrike Holdings with a Buy rating and $280 price target. The analyst views CrowdStrike as a "long-term secular winner" in security due to its native cloud platform advantage and its expansion into tangential segments to capture a greater share of security budgets. CrowdStrike's "first-mover cloud advantage" makes it an important component of a robust cybersecurity framework, Walkley tells investors in a research note. He believes there is "ample room for share price expansion longer term" as CrowdStrike continues to drive "best-in-class" security software growth metrics.

Our Take:  "So just starting coverage for these guys? A little late here Canaccord!! It has tripled in the last year! We like it as a good longer-term growth tech name in a good business area. We only have one issue with this stock, that being the valuation is already a bit high".


ImmunoGen price target raised to $12 from $11 at H.C. Wainwright

H.C. Wainwright analyst Swayampakula Ramakanth raised the firm's price target on ImmunoGen to $12 from $11 and reiterates a Buy rating on the shares following the company's Q4 results.

Our Take:  "IMGN has gotten our attention and after it's big jump recently we are waiting for it to settle before we take action. We see a lot of potential with this little biotech. Current trade idea is to sell some naked puts".


$IMGN, ImmunoGen, Inc. / H1

Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal.

If you liked this article, please click the LIKE (thumbs up) button.

Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so).

Follow us/bookmark us and check back occasionally for additional articles or comments on our page...

Wild Tiger Trading - start/main page.

.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue